Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small amount of redness, tenderness or mild swelling at the injection site is common after a Mounjaro dose and usually settles within a day or two. Most people who notice a site reaction are experiencing a normal response to the injection itself, not a sign that something has gone wrong. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before treatment starts, and that assessment includes going through what to expect at the injection site.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people assume when they notice redness or a small raised area after injecting is that their body is fighting the drug itself. That's rarely what's happening. The skin responds to the mechanical act of the needle, the pressure of the liquid going in and the preservative in the formulation. A brief flare of redness, a patch of mild swelling or localised itching that fades within 24 to 48 hours sits well within what the Mounjaro SmPC describes as expected. The NHS medicines page for tirzepatide lists injection-site reactions among the common effects that affect up to one in ten people.
That said, normal and harmless are not the same as 'ignore it'. Tracking how your skin responds after each pen is genuinely useful. A quick check before and after each injection (running a finger over the site to notice whether a lump is still there from last week) takes under a minute and can catch a build-up early. Consistent soreness at the same spot often just means you haven't moved the injection site far enough between doses.
Rotation matters more than most people realise. Moving to a different quadrant of the abdomen, or switching between the thigh and upper arm, gives each area time to recover. Injecting repeatedly into the same patch can create a hardened area under the skin that slows absorption and prolongs irritation. Our guide to Mounjaro side effects has more on the practical side of managing injection technique.
Normal site reactions share a few consistent features. They are small, typically no larger than a coin. They stay at the injection site rather than spreading outward. They are mild (itchy or tender rather than genuinely painful) and they improve on their own within one to two days without treatment. You might notice a faint bruise if a small blood vessel was nicked, which is also unremarkable.
Warmth over the site is common and can feel more noticeable in warm weather or after a bath. A small, transient lump can form if the pen was not pressed firmly enough against the skin or if the injection was not given at the right angle. These resolve without intervention. If you want to understand more about what a site reaction to tirzepatide typically involves and why it occurs, our dedicated page walks through the detail. People who have experience with other subcutaneous injections sometimes find they have fewer reactions from the start. If you have questions about technique specifically, the frequently asked questions section covers some of these practicalities, and our prescribers are available through aftercare seven days a week.
Some reactions fall outside the normal range. Get medical attention the same day (or call 999 if symptoms are severe) if you notice any of the following after injecting Mounjaro:
A reaction that spreads visibly beyond the injection site, developing into a larger red or inflamed area, could indicate cellulitis, a skin infection that needs antibiotics. A hard, swollen lump that persists for several weeks and does not reduce may be lipohypertrophy and is worth raising with your prescriber. Signs of a systemic allergic reaction (hives, difficulty breathing, swelling of the face or throat, a rapid or pounding heartbeat) require emergency care immediately.
Severe stomach pain that radiates to the back, with or without vomiting, is not a site reaction. It may point to pancreatitis, which the MHRA identified as an infrequent but serious risk in its January 2026 Drug Safety Update on GLP-1 medicines. Seek urgent help if you experience this, and stop injecting until you have spoken to a clinician.
If you are ever unsure whether what you are experiencing is within the expected range, our page on reactions to Mounjaro covers the full spectrum of what people report, from mild and expected through to signs that need prompt attention. You can also report any suspected side effect via Yellow Card, the MHRA's online reporting system, regardless of severity. Reporting helps build a more complete safety picture for everyone using the medicine.
A few small habits make a noticeable difference. Let the pen reach room temperature for about 20 to 30 minutes before injecting, cold liquid from the fridge is more likely to cause localised discomfort. Clean the skin with an alcohol swab and allow it to dry fully before inserting the needle; injecting through damp skin can carry bacteria into the site. Press the pen firmly and hold it in place for the full count after activating it, removing it too early can cause the dose to pool under the skin.
Choosing a clean, unaffected patch of skin each time helps considerably. Avoid areas that are bruised, scarred, swollen or already tender. If the same site keeps reacting more severely, our page on bad reactions to Mounjaro can help you identify whether what you're experiencing warrants medical attention or a change in technique. You can read more about the broader range of skin responses that some people notice on our page covering skin reactions to Mounjaro, or see the Mounjaro overview for a fuller picture of the treatment.
Our prescribers discuss suitability, expected side effects and injection technique as part of every consultation. If you haven't yet started treatment, check your eligibility through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.